© All rights reserved to Barnea Jaffa Lande Law offices

Together is empowering

Search by Practice

Client updates /  Redomiciliation

On April 12, 2019, Arcturus Therapeutics Ltd., an Israeli public company traded on NASDAQ, published in the United States a prospectus and proxy statement (convening a general meeting of shareholders of the company). Publishing the prospectus is an advanced step toward completing an arrangement between the company and its shareholders.
Categories: Capital Markets | Corporate | IPOs and Public Offerings | Ongoing Counsel
Enter your email for newsletter sign up: